These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
57-1222280
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
1250 Broadway, 31st Floor
New York, NY 10001
|
10001
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
(877) 292-8767
(Registrant’s telephone number, including area code)
|
|
|
Large accelerated filer
|
¨
|
Accelerated filer
|
¨
|
|
Non-accelerated filer
|
x
|
Smaller reporting company
|
¨
|
|
|
FINANCIAL INFORMATION
|
|
Item
1.
|
Financial Statements
|
|
March 31,
2015
|
December 31,
2014
|
|||||||
|
(unaudited)
|
||||||||
|
Assets
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 77,919 | $ | 76,593 | ||||
|
Short-term deposits
|
35,102 | 35,102 | ||||||
|
Trade receivables (net of allowance for doubtful accounts of $149 at March 31, 2015 and December 31, 2014)
|
20,643 | 37,869 | ||||||
|
Prepaid expenses and other current assets
|
2,354 | 2,962 | ||||||
|
Total current assets
|
136,018 | 152,526 | ||||||
|
Long-term assets:
|
||||||||
|
Other assets
|
326 | 332 | ||||||
|
Property and equipment, net
|
5,474 | 3,989 | ||||||
|
Total long-term assets
|
5,800 | 4,321 | ||||||
|
Total assets
|
$ | 141,818 | $ | 156,847 | ||||
|
Liabilities and stockholders’ equity
|
||||||||
|
Current liabilities:
|
||||||||
|
Trade payables
|
$ | 2,122 | $ | 2,703 | ||||
|
Accrued expenses and other liabilities
|
14,480 | 16,754 | ||||||
|
Deferred revenues
|
31,891 | 33,753 | ||||||
|
Total current liabilities
|
48,493 | 53,210 | ||||||
|
Long-term liabilities:
|
||||||||
|
Deferred revenues
|
3,225 | 3,464 | ||||||
|
Severance pay
|
1,449 | 1,449 | ||||||
|
Other liabilities
|
4,182 | 3,698 | ||||||
|
Total long-term liabilities
|
8,856 | 8,611 | ||||||
|
Stockholders’ equity:
|
||||||||
|
Share capital
|
||||||||
|
Common stock of $ 0.001 par value - Authorized: 200,000,000 shares at March 31, 2015 and December 31, 2014; Issued and outstanding: 24,844,646 shares at March 31, 2015 and 24,685,604 shares at December 31, 2014
|
25 | 25 | ||||||
|
Accumulated other comprehensive loss
|
(446 | ) | (326 | ) | ||||
|
Additional paid-in capital
|
164,711 | 162,478 | ||||||
|
Accumulated deficit
|
(79,821 | ) | (67,151 | ) | ||||
|
Total stockholders’ equity
|
84,469 | 95,026 | ||||||
|
Total liabilities and stockholders’ equity
|
$ | 141,818 | $ | 156,847 | ||||
|
Three Months Ended
March 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
Revenues:
|
||||||||
|
Licenses
|
$ | 10,158 | $ | 8,053 | ||||
|
Maintenance and services
|
12,828 | 9,402 | ||||||
|
Total revenues
|
22,986 | 17,455 | ||||||
|
Cost of revenues
|
2,833 | 2,042 | ||||||
|
Gross profit
|
20,153 | 15,413 | ||||||
|
Operating costs and expenses:
|
||||||||
|
Research and development
|
7,733 | 6,439 | ||||||
|
Sales and marketing
|
20,191 | 14,241 | ||||||
|
General and administrative
|
3,780 | 2,665 | ||||||
|
Total operating expenses
|
31,704 | 23,345 | ||||||
|
Operating loss
|
(11,551 | ) | (7,932 | ) | ||||
|
Financial expenses and other, net
|
(1,041 | ) | (38 | ) | ||||
|
Loss before income taxes
|
(12,592 | ) | (7,970 | ) | ||||
|
Income taxes
|
(78 | ) | (104 | ) | ||||
|
Net loss
|
$ | (12,670 | ) | $ | (8,074 | ) | ||
|
Net loss per share of common stock, basic and diluted
|
$ | (0.51 | ) | $ | (0.73 | ) | ||
|
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted
|
24,741,306 | 11,082,770 | ||||||
|
Three Months Ended
March 31
|
||||||||
|
2015
|
2014
|
|||||||
|
Net loss
|
$ | (12,670 | ) | $ | (8,074 | ) | ||
|
Other comprehensive loss:
|
||||||||
|
Unrealized losses on derivative instruments
|
(120 | ) | (22 | ) | ||||
|
Total other comprehensive loss
|
(120 | ) | (22 | ) | ||||
|
Comprehensive loss
|
$ | (12,790 | ) | $ | (8,096 | ) | ||
|
Preferred stock
|
Common stock
|
Additional
paid-in
|
Accumulated
other
comprehensive
|
Accumulated
|
Total
stockholders’
equity
|
|||||||||||||||||||||||||||
|
Number
|
Amount
|
Number
|
Amount
|
capital
|
loss
|
deficit
|
(deficiency)
|
|||||||||||||||||||||||||
|
(in thousands, except share data)
|
||||||||||||||||||||||||||||||||
|
Balance as of January 1, 2014
|
15,082,141 | $ | 43,775 | 3,953,314 | $ | 4 | $ | 4,741 | $ | — | $ | (47,753 | ) | $ | (43,008 | ) | ||||||||||||||||
|
Issuance of common stock upon initial public offering (net of issuance costs of $2,376)
|
— | — | 5,300,436 | 5 | 106,066 | — | — | 106,071 | ||||||||||||||||||||||||
|
Conversion of preferred stock to common stock upon initial public offering
|
(15,082,141 | ) | (43,775 | ) | 15,082,141 | 15 | 43,760 | — | — | 43,775 | ||||||||||||||||||||||
|
Conversion of warrants to purchase preferred stock into warrants to purchase common stock
|
— | — | — | — | 2,866 | — | — | 2,866 | ||||||||||||||||||||||||
|
Exercise of warrants to purchase common stock
|
— | — | 107,217 | * | ) | — | — | — | — | |||||||||||||||||||||||
|
Stock-based compensation expense
|
— | — | — | — | 4,664 | — | — | 4,664 | ||||||||||||||||||||||||
|
Exercise of stock options
|
— | — | 238,951 | * | ) | 381 | — | — | 382 | |||||||||||||||||||||||
|
Exercise of restricted stock units
|
— | — | 3,545 | * | ) | — | — | — | — | |||||||||||||||||||||||
|
Unrealized loss on derivative instruments
|
— | — | — | — | — | (326 | ) | — | (326 | ) | ||||||||||||||||||||||
|
Net loss
|
— | — | — | — | — | — | (19,398 | ) | (19,398 | ) | ||||||||||||||||||||||
|
Balance as of December 31, 2014
|
— | — | 24,685,604 | 25 | 162,478 | (326 | ) | (67,151 | ) | 95,026 | ||||||||||||||||||||||
|
Stock-based compensation expense
|
— | — | — | — | 1,685 | — | — | 1,685 | ||||||||||||||||||||||||
|
Exercise of stock options
|
— | — | 156,382 | * | ) | 548 | — | — | 548 | |||||||||||||||||||||||
|
Exercise of restricted stock units
|
— | — | 2,660 | * | ) | — | — | — | — | |||||||||||||||||||||||
|
Unrealized loss on derivative instruments
|
— | — | — | — | — | (120 | ) | — | (120 | ) | ||||||||||||||||||||||
|
Net loss
|
— | — | — | — | — | — | (12,670 | ) | (12,670 | ) | ||||||||||||||||||||||
|
Balance as of March 31, 2015 (unaudited)
|
— | $ | — | 24,844,646 | $ | 25 | $ | 164,711 | $ | (446 | ) | $ | (79,821 | ) | $ | 84,469 | ||||||||||||||||
|
|
*)
|
Represents an amount lower than $ 1.
|
|
Three Months Ended
March 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
Cash flows from operating activities
:
|
||||||||
|
Net loss
|
$ | (12,670 | ) | $ | (8,074 | ) | ||
|
Adjustments to reconcile net loss to net cash provided by operating activities:
|
||||||||
|
Depreciation
|
344 | 254 | ||||||
|
Stock-based compensation
|
1,685 | 646 | ||||||
|
Amortization of deferred charges related to loan
|
- | 31 | ||||||
|
Capital loss from disposal of fixed asset
|
(1 | ) | - | |||||
|
Changes in assets and liabilities:
|
||||||||
|
Trade receivables
|
17,226 | 14,014 | ||||||
|
Prepaid expenses and other current assets
|
1,064 | (284 | ) | |||||
|
Trade payables
|
(581 | ) | (74 | ) | ||||
|
Accrued expenses and other liabilities
|
(2,394 | ) | (1,069 | ) | ||||
|
Increase in severance pay, net
|
- | 314 | ||||||
|
Deferred revenues
|
(2,101 | ) | (1,424 | ) | ||||
|
Other long term liabilities
|
(1,327 | ) | 3 | |||||
|
Net cash provided by operating activities
|
1,245 | 4,337 | ||||||
|
Cash flows from investing activities
:
|
||||||||
|
Decrease in short-term deposit
|
- | 3,987 | ||||||
|
Decrease in long-term deposits
|
- | 37 | ||||||
|
Decrease (increase) in restricted cash
|
6 | (15 | ) | |||||
|
Purchase of property and equipment
|
(473 | ) | (608 | ) | ||||
|
Net cash provided by (used in) investing activities
|
(467 | ) | 3,401 | |||||
|
Cash flows from financing activities
:
|
||||||||
|
Exercise of employee stock options
|
548 | 13 | ||||||
|
Payment of deferred equity offering cost
|
- | (335 | ) | |||||
|
Net proceeds from initial public offering
|
- | 108,447 | ||||||
|
Net cash provided by financing activities
|
548 | 108,125 | ||||||
|
Increase in cash and cash equivalents
|
1,326 | 115,863 | ||||||
|
Cash and cash equivalents at beginning of period
|
76,593 | 9,633 | ||||||
|
Cash and cash equivalents at end of period
|
$ | 77,919 | $ | 125,496 | ||||
|
Supplemental disclosure of non-cash flow information
:
|
||||||||
|
Conversion of preferred stock to common stock
|
- | 43,775 | ||||||
|
Conversion of liability warrants to equity
|
- | 2,866 | ||||||
|
Deferred rent fixed asset additions
|
1,355 | - | ||||||
|
Deferred offering costs not yet paid
|
- | 846 | ||||||
| $ | 1,355 | $ | 47,487 | |||||
|
Supplemental disclosures of cash flow information
:
|
||||||||
|
Cash paid for income taxes
|
$ | 33 | $ | 28 | ||||
|
NOTE 1:-
|
GENERAL
|
|
|
a.
|
Varonis Systems, Inc. (“VSI” and together with its subsidiaries, collectively, the “Company”) was incorporated under the laws of the State of Delaware on November 3, 2004 and commenced operations on January 1, 2005.
|
|
|
b.
|
Initial Public Offering:
|
|
|
c.
|
The significant accounting policies applied in the Company’s audited annual consolidated financial statements as of December 31, 2014 are applied consistently in these financial statements.
|
|
|
d.
|
Basis of Presentation:
|
|
|
e.
|
Derivative Instruments:
|
|
Liabilities as of
March 31, 2015
(unaudited)
|
Liabilities as of
December 31, 2014
|
|||||||||||||||
|
Notional
Amount
|
Fair
Value
|
Notional
Amount
|
Fair
Value
|
|||||||||||||
|
Foreign Exchange Forward Contract Derivatives in cash flow hedging relationships - included in accrued expenses and other liabilities
|
$ | 23,765 | $ | (446 | ) | $ | 30,662 | $ | (326 | ) | ||||||
|
NOTE 2:-
|
FAIR VALUE MEASUREMENTS
|
|
|
•
|
Level 1: Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
|
|
|
•
|
Level 2: Observable inputs that reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
|
|
|
•
|
Level 3: Unobservable inputs reflecting our own assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.
|
|
As of March 31, 2015 (unaudited)
|
As of December 31, 2014
|
|||||||||||||||||||||||||||||||
|
Level I
|
Level II
|
Level III
|
Fair
Value
|
Level I
|
Level II
|
Level III
|
Fair
Value
|
|||||||||||||||||||||||||
|
Financial liabilities:
|
||||||||||||||||||||||||||||||||
|
Forward foreign exchange contracts
|
— | (446 | ) | — | (446 | ) | — | (326 | ) | — | (326 | ) | ||||||||||||||||||||
|
Total financial liabilities
|
$ | — | $ | (446 | ) | — | $ | (446 | ) | $ | — | $ | (326 | ) | — | $ | (326 | ) | ||||||||||||||
|
NOTE 3:-
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
|
|
a.
|
Liens:
|
|
|
b.
|
Lease Commitments:
|
|
unaudited
|
||||
|
2015
|
$ | 1,597 | ||
|
2016
|
3,468 | |||
|
2017
|
2,880 | |||
|
2018
|
2,718 | |||
|
2019
|
2,748 | |||
|
Thereafter
|
17,419 | |||
| $ | 30,830 | |||
|
|
c.
|
On March 31, 2014, the Company entered into a promissory note and related security documents with Bank Leumi USA. The Company may borrow up to $7,000 against certain of its accounts receivable outstanding amount, based on several conditions, at an annual interest rate of the Wall Street Journal Prime Rate less 0.15%. As of March 31, 2015, that rate amounted to 3.1%. This promissory note enables the Company to engage in foreign currency hedging transactions with Bank Leumi USA to manage exposure to foreign currency risk without restricted cash requirements. The Company may borrow under the promissory note until May 15, 2015 at which time the principal sum of each such loan, together with accrued and unpaid interest payable, will become due and payable. As of March 31, 2015, the Company had no balance outstanding under the promissory note. As part of the transaction, the Company granted the lender a security interest in its personal property, excluding intellectual property and other intangible assets. The promissory note also contains customary events of default
.
|
|
NOTE 4:–
|
STOCKHOLDERS’ EQUITY
|
|
|
a.
|
On December 30, 2005, the Company’s board of directors adopted the Varonis Systems, Inc. 2005 Stock Plan (the “2005 Stock Plan”). As of December 31, 2013, the Company had reserved 4,713,319 shares of common stock available for issuance to employees, directors, officers and consultants of the Company and its subsidiaries. The options generally vest over four years. No awards were granted under the 2005 Stock Plan subsequent to December 31, 2013, and no further awards will be granted under the 2005 Stock Plan.
|
|
Period ended
March 31, 2015 (unaudited)
|
||||||||||||||||
|
Number
|
Average
exercise price
|
Aggregate
intrinsic value
(in thousands)
|
Average
remaining
contractual life
(years)
|
|||||||||||||
|
Options outstanding at the beginning of the year
|
4,080,611 | $ | 9.697 | $ | 95,855 | 6.092 | ||||||||||
|
Granted
|
161,200 | $ | 29.880 | |||||||||||||
|
Exercised
|
(140,716 | ) | $ | 3.728 | ||||||||||||
|
Forfeited
|
(58,995 | ) | $ | 28.659 | ||||||||||||
|
Options outstanding at the end of the period
|
4,042,100 | $ | 10.433 | $ | 64,869 | 6.049 | ||||||||||
|
Vested and expected to vest
|
3,932,028 | $ | 10.064 | $ | 64,408 | 5.961 | ||||||||||
|
Options exercisable at the end of the period
|
2,578,803 | $ | 3.488 | $ | 57,852 | 4.326 | ||||||||||
|
|
b.
|
The options outstanding as of March 31, 2015 (unaudited) have been separated into ranges of exercise price as follows:
|
|
Range of exercise price
|
Options
outstanding
as of
March 31,
2015
|
Weighted
average
remaining
contractual
life (years)
|
Weighted
average
exercise price
|
Options
exercisable
as of
March 31,
2015
|
Weighted
average
remaining
contractual
life (years)
|
Weighted
average
exercise price
of options
exercisable
|
|||||||||||||||||||
| $ 0.070-0.901 | 517,811 | 2.483 | $ | 0.812 | 517,811 | 2.483 | $ | 0.812 | |||||||||||||||||
| $ 1.039-1.576 | 1,635,172 | 4.021 | $ | 1.263 | 1,635,172 | 4.021 | $ | 1.263 | |||||||||||||||||
| $ 6.230-8.800 | 154,818 | 6.645 | $ | 6.754 | 126,326 | 6.568 | $ | 6.761 | |||||||||||||||||
| $ 12.470 | 387,601 | 7.927 | $ | 12.470 | 185,324 | 7.902 | $ | 12.470 | |||||||||||||||||
| $ 21.000-24.230 | 1,004,548 | 9.233 | $ | 21.609 | 66,556 | 8.625 | $ | 21.756 | |||||||||||||||||
| $ 29.880 | 154,200 | 9.901 | $ | 29.880 | - | - | - | ||||||||||||||||||
| $ 39.860 | 187,950 | 8.981 | $ | 39.860 | 47,614 | 8.981 | $ | 39.860 | |||||||||||||||||
| 4,042,100 | 6.049 | $ | 10.433 | 2,578,803 | 4.326 | $ | 3.488 | ||||||||||||||||||
|
|
c.
|
The fair value of stock option grants for the period ended March 31, 2015 was estimated using the following weighted average assumptions:
|
|
Period ended
March 31, 2015
|
||||
|
unaudited
|
||||
|
Expected dividend yield
|
0 | % | ||
|
Expected volatility
|
65 | % | ||
|
Risk-free interest rate
|
1.94 | % | ||
|
Expected term (years)
|
6.25 | |||
|
|
d.
|
Options issued to consultants:
|
|
Options for
shares of
common stock
|
Exercise price
per share
|
Options
exercisable
|
Exercisable
through
|
||||||||||
|
(number)
|
(number)
|
||||||||||||
|
February 2013
|
3,500 | $ | 12.470 | 1,582 |
February 2023
|
||||||||
|
August 2013
|
5,000 | $ | 21.140 | 1,975 |
August 2023
|
||||||||
|
October 2013
|
1,084 | $ | 24.230 | 276 |
October 2023
|
||||||||
|
March 2014
|
16,450 | $ | 39.860 | 4,115 |
March 2024
|
||||||||
|
May 2014
|
8,700 | $ | 22.010 | - |
May 2024
|
||||||||
|
August 2014
|
36,250 | $ | 21.000 | - |
August 2024
|
||||||||
|
November 2014
|
12,000 | $ | 21.660 | - |
November 2024
|
||||||||
| 82,984 | 7,948 | ||||||||||||
|
|
e.
|
Stock-based compensation expense for employees and consultants:
|
|
Three Months Ended March 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
(unaudited)
|
||||||||
|
(in thousands)
|
||||||||
|
Cost of revenues
|
$ | 91 | $ | 20 | ||||
|
Research and development
|
467 | 199 | ||||||
|
Sales and marketing
|
737 | 340 | ||||||
|
General and administrative
|
390 | 87 | ||||||
|
Total
|
$ | 1,685 | $ | 646 | ||||
|
f.
|
Restricted stock units for employees, consultants and non-employee directors:
|
|
|
Number of
shares
underlying
outstanding
restricted stock
units
|
Weighted-
average
grant date
fair value
|
||||||
|
Unvested balance - January 1, 2015
|
27,470 | $ | 21.00 | |||||
|
Granted
|
252,150 | $ | 29.88 | |||||
|
Vested
|
(2,478 | ) | $ | 21.00 | ||||
|
Forfeited
|
(6,140 | ) | $ | 22.45 | ||||
|
Unvested balance - March 31, 2015
|
271,002 | $ | 29.23 | |||||
|
Expected to vest – March 31, 2015
|
249,139 | |||||||
|
NOTE 5:-
|
GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA
|
|
Three Months Ended March 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
(unaudited)
|
||||||||
|
(in thousands)
|
||||||||
|
Revenues based on customer’s location:
|
||||||||
|
United States
|
$ | 13,106 | $ | 9,070 | ||||
|
EMEA (*)
|
7,993 | 6,943 | ||||||
|
Rest of the World
|
1,887 | 1,442 | ||||||
|
Total revenues
|
$ | 22,986 | $ | 17,455 | ||||
|
(*)
|
Sales to customers in France accounted for $2,318 for the three months ended March 31, 2015. Sales to customers in the UK accounted for $1,880 for the three months ended March 31, 2014.
|
|
March 31,
2015
|
December 31,
2014
|
|||||||
|
Unaudited
|
Audited
|
|||||||
|
(in thousands)
|
||||||||
|
Long-lived assets by geographic region:
|
||||||||
|
United States
|
$ | 3,771 | $ | 2,146 | ||||
|
Israel
|
1,520 | 1,648 | ||||||
|
Other
|
183 | 195 | ||||||
| $ | 5,474 | $ | 3,989 | |||||
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
Three Months Ended
March 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
(as a percentage of total revenues)
|
||||||||
|
Revenues:
|
||||||||
|
Licenses
|
44.2 | % | 46.1 | % | ||||
|
Maintenance and services
|
55.8 | 53.9 | ||||||
|
Total revenues
|
100.0 | % | 100.0 | % | ||||
|
Three Months Ended
March 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
(unaudited)
(in thousands)
|
||||||||
|
Statement of Operations Data:
|
||||||||
|
Revenues:
|
||||||||
|
Licenses
|
$ | 10,158 | $ | 8,053 | ||||
|
Maintenance and services
|
12,828 | 9,402 | ||||||
|
Total revenues
|
22,986 | 17,455 | ||||||
|
Cost of revenues
|
2,833 | 2,042 | ||||||
|
Gross profit
|
20,153 | 15,413 | ||||||
|
Operating costs and expenses:
|
||||||||
|
Research and development
|
7,733 | 6,439 | ||||||
|
Sales and marketing
|
20,191 | 14,241 | ||||||
|
General and administrative
|
3,780 | 2,665 | ||||||
|
Total operating expenses
|
31,704 | 23,345 | ||||||
|
Operating loss
|
(11,551 | ) | (7,932 | ) | ||||
|
Financial expenses, net
|
(1,041 | ) | (38 | ) | ||||
|
Loss before income taxes, net
|
(12,592 | ) | (7,970 | ) | ||||
|
Income taxes
|
(78 | ) | (104 | ) | ||||
|
Net loss
|
$ | (12,670 | ) | $ | (8,074 | ) | ||
|
Three Months Ended
March 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
(
as a percentage of total revenues)
|
||||||||
|
Statement of Operations Data:
|
||||||||
|
Revenues:
|
||||||||
|
Licenses
|
44.2 | % | 46.1 | % | ||||
|
Maintenance and services
|
55.8 | 53.9 | ||||||
|
Total revenues
|
100.0 | 100.0 | ||||||
|
Cost of revenues
|
12.3 | 11.7 | ||||||
|
Gross profit
|
87.7 | 88.3 | ||||||
|
Operating costs and expenses:
|
||||||||
|
Research and development
|
33.6 | 36.9 | ||||||
|
Sales and marketing
|
87.8 | 81.5 | ||||||
|
General and administrative
|
16.5 | 15.3 | ||||||
|
Total operating expenses
|
137.9 | 133.7 | ||||||
|
Operating loss
|
(50.2 | ) | (45.4 | ) | ||||
|
Financial expenses, net
|
(4.5 | ) | (0.3 | ) | ||||
|
Loss before income taxes, net
|
(54.7 | ) | (45.7 | ) | ||||
|
Income taxes
|
(0.4 | ) | (0.6 | ) | ||||
|
Net loss
|
(55.1 | )% | (46.3 | )% | ||||
|
Three Months Ended
March 31,
|
||||||||||||
|
2015
|
2014
|
% Change
|
||||||||||
|
(unaudited)
(in thousands)
|
||||||||||||
|
Revenues:
|
||||||||||||
|
Licenses
|
$ | 10,158 | $ | 8,053 | 26.1 | % | ||||||
|
Maintenance and services
|
12,828 | 9,402 | 36.4 | % | ||||||||
|
Total revenues
|
$ | 22,986 | $ | 17,455 | 31.7 | % | ||||||
|
Three Months Ended
March 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
(as a percentage of total revenues)
|
||||||||
|
Revenues:
|
||||||||
|
Licenses
|
44.2 | % | 46.1 | % | ||||
|
Maintenance and services
|
55.8 | % | 53.9 | % | ||||
|
Total revenues
|
100.0 | % | 100.0 | % | ||||
|
Three Months Ended
March 31,
|
||||||||||||
|
2015
|
2014
|
% Change
|
||||||||||
|
(unaudited)
(in thousands)
|
||||||||||||
|
Cost of revenues
|
$ | 2,833 | $ | 2,042 | 38.7 | % | ||||||
|
Three Months Ended
March 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
(as a percentage of total revenues)
|
||||||||
|
Total gross margin
|
87.7 | % | 88.3 | % | ||||
|
Three Months Ended
March 31,
|
||||||||||||
|
2015
|
2014
|
% Change
|
||||||||||
|
(unaudited)
(in thousands)
|
||||||||||||
|
Operating costs and expenses:
|
||||||||||||
|
Research and development
|
$ | 7,733 | $ | 6,439 | 20.1 | % | ||||||
|
Sales and marketing
|
20,191 | 14,241 | 41.8 | % | ||||||||
|
General and administrative
|
3,780 | 2,665 | 41.8 | % | ||||||||
|
Total operating expenses
|
$ | 31,704 | $ | 23,345 | 35.8 | % | ||||||
|
Three Months Ended
March 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
(as a percentage of total revenues)
|
||||||||
|
Operating costs and expenses:
|
||||||||
|
Research and development
|
33.6 | % | 36.9 | % | ||||
|
Sales and marketing
|
87.8 | % | 81.5 | % | ||||
|
General and administrative
|
16.5 | % | 15.3 | % | ||||
|
Total operating expenses
|
137.9 | % | 133.7 | % | ||||
|
Three Months Ended
March 31,
|
||||||||||||
|
2015
|
2014
|
% Change
|
||||||||||
|
(unaudited)
|
||||||||||||
|
(in thousands)
|
||||||||||||
|
Financial expenses, net
|
$ | 1,041 | $ | 38 | 2,639 | % | ||||||
|
Three Months Ended
March 31,
|
||||||||||||
|
2015
|
2014
|
% Change
|
||||||||||
|
(unaudited)
|
||||||||||||
|
(in thousands)
|
||||||||||||
|
Income taxes
|
$ | 78 | $ | 104 | (25 | )% | ||||||
|
Three Months Ended
March 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
(unaudited)
|
||||||||
|
(in thousands)
|
||||||||
|
Net cash provided by operating activities
|
$ | 1,245 | $ | 4,337 | ||||
|
Net cash provided by (used in) investing activities
|
(467 | ) | 3,401 | |||||
|
Net cash provided by financing activities
|
548 | 108,125 | ||||||
|
Increase in cash and cash equivalents
|
$ | 1,326 | $ | 115,863 | ||||
|
Payments Due by Period
|
||||||||||||||||||||
|
Total
|
Less Than
1 Year
|
1-3 Years
|
3-5 Years
|
More Than
5 Years
|
||||||||||||||||
|
(in thousands)
|
||||||||||||||||||||
|
Operating lease obligation
|
$ | 30,830 | $ | 1,597 | $ | 6,348 | $ | 5,466 | $ | 17,419 | ||||||||||
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
Item 4.
|
Controls and Procedures
|
|
Item 1.
|
Legal Proceedings
|
|
Item 1A.
|
Risk Factors
|
|
|
•
|
effectively recruit, integrate, train and motivate a large number of new employees, including our sales force and engineers, while retaining existing employees, maintaining the beneficial aspects of our corporate culture and effectively executing our business plan;
|
|
|
•
|
satisfy existing customers and attract new customers;
|
|
|
•
|
effectively manage existing channel partnerships and expand to new ones;
|
|
|
•
|
successfully introduce new products and enhancements;
|
|
|
•
|
improve our key business applications and processes to support our business needs;
|
|
|
•
|
enhance information and communication systems to ensure that our employees and offices around the world are well-coordinated and can effectively communicate with each other and our growing customer base;
|
|
|
•
|
enhance our internal controls to ensure timely and accurate reporting of all of our operations and financial results;
|
|
|
•
|
protect and further develop our strategic assets, including our intellectual property rights; and
|
|
|
•
|
make sound business decisions in light of the scrutiny associated with operating as a public company.
|
|
|
•
|
failure to accurately predict market demand in terms of product functionality and to supply products that meet this demand in a timely fashion;
|
|
|
•
|
inability to interoperate effectively with the database technologies and file systems of prospective customers;
|
|
|
•
|
defects, errors or failures;
|
|
|
•
|
negative publicity or customer complaints about performance or effectiveness; and
|
|
|
•
|
poor business conditions, causing customers to delay IT purchases.
|
|
|
•
|
maintain and expand our business, including our customer base and operations, to support our growth, both domestically and internationally;
|
|
|
•
|
develop new products and services and bring products and services in beta to market;
|
|
|
•
|
renew maintenance and support agreements with, and sell additional products to, existing customers;
|
|
|
•
|
hire, integrate, train and retain skilled talent, including members of our sales force and software engineers; and
|
|
|
•
|
maintain compliance with applicable governmental regulations and other legal obligations, including those related to intellectual property, international sales and taxation.
|
|
|
•
|
our ability to continue to offer high-quality, innovative and error- and bug-free products;
|
|
|
•
|
our ability to maintain customer satisfaction with our products;
|
|
|
•
|
our ability to be responsive to customer concerns and provide high quality customer support, training and professional services;
|
|
|
•
|
our marketing efforts;
|
|
|
•
|
any misuse or perceived misuse of our products;
|
|
|
•
|
positive or negative publicity;
|
|
|
•
|
interruptions, delays or attacks on our website; and
|
|
|
•
|
litigation or regulatory-related developments.
|
|
|
•
|
sales and customer service challenges associated with operating in different countries;
|
|
|
•
|
increased management, travel, infrastructure and legal compliance costs associated with having multiple international operations;
|
|
|
•
|
difficulties in receiving payments from different geographies, including difficulties associated with currency fluctuations, payment cycles, transfer of funds or collecting accounts receivable, especially in emerging markets;
|
|
|
•
|
variations in economic or political conditions between each country or region;
|
|
|
•
|
economic uncertainty around the world and adverse effects arising from economic interdependencies across countries and regions;
|
|
|
•
|
compliance with foreign laws and regulations and the risks and costs of non-compliance with such laws and regulations;
|
|
|
•
|
compliance with laws and regulations for foreign operations, including the U.S. Foreign Corrupt Practices Act of 1977, or the FCPA, the U.K. Bribery Act of 2010, import and export control laws, tariffs, trade barriers, economic sanctions and other regulatory or contractual limitations on our ability to sell our software in certain foreign markets, and the risks and costs of non-compliance;
|
|
|
•
|
heightened risks of unfair or corrupt business practices in certain geographies and of improper or fraudulent sales arrangements that may impact financial results and result in restatements of financial statements and irregularities in financial statements;
|
|
|
•
|
reduced protection for intellectual property rights in certain countries and practical difficulties and costs of enforcing rights abroad; and
|
|
|
•
|
compliance with the laws of numerous foreign taxing jurisdictions and overlapping of different tax regimes.
|
|
|
•
|
changes in public sector fiscal or contracting policies;
|
|
|
•
|
decreases in available public sector funding;
|
|
|
•
|
changes in public sector programs or applicable requirements;
|
|
|
•
|
the adoption of new laws or regulations or changes to existing laws or regulations;
|
|
|
•
|
potential delays or changes in the public sector appropriations or other funding authorization processes; and
|
|
|
•
|
delays in the payment of our invoices by public sector payment offices.
|
|
|
•
|
actual or anticipated fluctuations in our results or those of our competitors;
|
|
|
•
|
the financial projections we may provide to the public, any changes in these projections or our failure to meet these projections;
|
|
|
•
|
failure of securities analysts to initiate or maintain coverage of our company, changes in financial estimates by any securities analysts who follow our company, or our failure to meet these estimates or the expectations of investors;
|
|
|
•
|
ratings changes by any securities analysts who follow our company;
|
|
|
•
|
announcements of new products, services or technologies, commercial relationships, acquisitions or other events by us or our competitors;
|
|
|
•
|
fluctuations in stock market prices and trading volumes of securities of similar companies;
|
|
|
•
|
general market conditions and overall fluctuations in U.S. equity markets;
|
|
|
•
|
changes in accounting principles;
|
|
|
•
|
sales of large blocks of our common stock, including sales by our executive officers, directors and significant stockholders;
|
|
|
•
|
additions or departures of any of our key personnel;
|
|
|
•
|
lawsuits threatened or filed against us;
|
|
|
•
|
changing legal or regulatory developments in the United States and other countries; and
|
|
|
•
|
other events or factors, including those resulting from war, incidents of terrorism or responses to these events.
|
|
|
•
|
authorizing “blank check” preferred stock, which could be issued by the board without stockholder approval and may contain voting, liquidation, dividend and other rights superior to our common stock, which would increase the number of outstanding shares and could thwart a takeover attempt;
|
|
|
•
|
a classified board of directors whose members can only be dismissed for cause;
|
|
|
•
|
the prohibition on actions by written consent of our stockholders;
|
|
|
•
|
the limitation on who may call a special meeting of stockholders;
|
|
|
•
|
the establishment of advance notice requirements for nominations for election to our board of directors or for proposing matters that can be acted upon at stockholder meetings; and
|
|
|
•
|
the requirement of at least 75% of the outstanding capital stock to amend any of the foregoing second through fifth provisions.
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
|
Item 6.
|
Exhibits
|
|
Exhibit
Number
|
Description of the Document
|
||
|
3.1(1)
|
Amended and Restated Certificate of Incorporation
|
||
|
3.2(2)
|
Amended and Restated Bylaws
|
||
|
4.1(3)
|
Third Amended and Restated Investors’ Rights Agreement, dated as of February 24, 2011, by and among the Company and certain holders of the Company’s capital stock named therein
|
||
|
31.1
|
Rule 13a-14(a) Certification of Chief Executive Officer and President of the Company in accordance with Section 302 of the Sarbanes-Oxley Act of 2002
|
||
|
31.2
|
Rule 13a-14(a) Certification of Chief Financial Officer of the Company in accordance with Section 302 of the Sarbanes-Oxley Act of 2002
|
||
|
32.1*
|
Section 1350 Certification of Chief Executive Officer and President of the Company in accordance with Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
32.2*
|
Section 1350 Certification of Chief Financial Officer of the Company in accordance with Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
101
|
The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Loss, (iv) the Consolidated Statements of Cash Flows and (v) related notes to these consolidated financial statements, tagged as blocks of text and in detail
|
|
(*)
|
Document has been furnished, is not deemed filed and is not to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, irrespective of any general incorporation language contained in any such filing.
|
|
(1)
|
Filed as Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 8, 2014 (File No. 001-35324) (the “Company’s First Quarter 2014 Form 10-Q”) and incorporated herein by reference.
|
|
(2)
|
Filed as Exhibit 3.2 to the Company’s First Quarter 2014 Form 10-Q and incorporated herein by reference.
|
|
(3)
|
Filed as Exhibit 3.2 to the Company’s Registration Statement on Form S-1 (File 333-191840) with the SEC on October 22, 2013 and incorporated herein by reference.
|
|
VARONIS SYSTEMS, INC.
|
|||
|
May 7 2015
|
By:
|
/s/ Yakov Faitelson
|
|
|
Yakov Faitelson
|
|||
|
Chief Executive Officer and President
|
|||
|
May 7, 2015
|
By:
|
/s/ Gili Iohan
|
|
|
Gili Iohan
|
|||
|
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
|
|||
|
Exhibit
Number
|
Description of the Document
|
||
|
3.1(1)
|
Amended and Restated Certificate of Incorporation
|
||
|
3.2(2)
|
Amended and Restated Bylaws
|
||
|
4.1(3)
|
Third Amended and Restated Investors’ Rights Agreement, dated as of February 24, 2011, by and among the Company and certain holders of the Company’s capital stock named therein
|
||
|
31.1
|
Rule 13a-14(a) Certification of Chief Executive Officer and President of the Company in accordance with Section 302 of the Sarbanes-Oxley Act of 2002
|
||
|
31.2
|
Rule 13a-14(a) Certification of Chief Financial Officer of the Company in accordance with Section 302 of the Sarbanes-Oxley Act of 2002
|
||
|
32.1*
|
Section 1350 Certification of Chief Executive Officer and President of the Company in accordance with Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
32.2*
|
Section 1350 Certification of Chief Financial Officer of the Company in accordance with Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
101
|
The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2015, formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Loss, (iv) the Consolidated Statements of Cash Flows and (v) related notes to these consolidated financial statements, tagged as blocks of text and in detail
|
|
(*)
|
Document has been furnished, is not deemed filed and is not to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, irrespective of any general incorporation language contained in any such filing.
|
|
(1)
|
Filed as Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 8, 2014 (File No. 001-35324) (the “Company’s First Quarter 2014 Form 10-Q”) and incorporated herein by reference.
|
|
(2)
|
Filed as Exhibit 3.2 to the Company’s First Quarter 2014 Form 10-Q and incorporated herein by reference.
|
|
(3)
|
Filed as Exhibit 3.2 to the Company’s Registration Statement on Form S-1 (File 333-191840) with the SEC on October 22, 2013 and incorporated herein by reference.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|